tbuckley/cabot-search huggingface dataset:
Surgery for Peptic Ulcer
Authors: J. P. Lythgoe
Journal: BMJ (1964)

<h3></h3> Brief introduction: In healthy adults, the right atrium (RA) serves as a reservoir for the systemic flow return from the superior vena cava (SVC) and inferior vena cava (IVC), preparing the two flows to be transferred to the right ventricle (RV) and pulmonary circulation. This study aims to quantify the haemodynamics of the RA and the associated SVC and IVC inflows, which have not been fully understood to date. <h3>Basic Methods</h3> Eighteen adults with structurally normal hearts underwent 4D flow magnetic resonance imaging. The cardiac cycle was resolved to 20 temporal phases with a spatial resolution of 3×3×3 mm cube. Analysis included objective visualisation of the flow structures in the RA identified by three different vortex identification criteria, kinetic energy (KE), enstrophy and dissipation. KE and helicity flux were also assessed in both caval veins. <h3>Main Results</h3> Vortex identification methods confirmed that in the majority of participants the blood flow from the caval veins filling the RA during ventricular systole is not chaotic, but rather forms an organised pattern of a single coherent forward turning vortex structure. Thirteen participants displayed a single vortex flow structure, four showed multiple vortices and one had a helical flow pattern without a clear vortex structure. A strong positive correlation exists between the flow KE and enstrophy density. <h3>Conclusions and Implications</h3> This study suggests that flow energy in the RA is mainly rotational, part of which is convected by the highly helical SVC and IVC inflows. Multiple vortices tend to be associated with higher dissipation rates in the central RA region due to turbulence. The rotational nature of the flow in the RA maintains KE better than non-rotational flow. RA flow characteristics are highly related to the helicity content in the caval veins, as well as the KE flux intensity. Lower caval helicity or IVC KE flux dominance tends to favour single vortex formation while the opposite tends to lead to multiple vortices or the rare helical flow patterns. Atria lacking single vortex flow are inclined to have a larger energy input from atrial contraction. <h3>Conflict of Interest</h3> n/a
Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug‐resistant <i>Plasmodium falciparum</i>
Authors: Lian‐Shun Feng, Zhi Xu, Le Chang, Chuan Li, Xiao‐Fei Yan, Chuan Gao, Chao Ding, Feng Zhao, Feng Shi, Xiang Wu
Journal: Medicinal Research Reviews (2019)

Abstract Malaria is a tropical disease, leading to around half a million deaths annually. Antimalarials such as quinolines are crucial to fight against malaria, but malaria control is extremely challenged by the limited pipeline of effective pharmaceuticals against drug‐resistant strains of Plasmodium falciparum which are resistant toward almost all currently accessible antimalarials. To tackle the growing resistance, new antimalarial drugs are needed urgently. Hybrid molecules which contain two or more pharmacophores have the potential to overcome the drug resistance, and hybridization of quinoline privileged antimalarial building block with other antimalarial pharmacophores may provide novel molecules with enhanced in vitro and in vivo activity against drug‐resistant (including multidrug‐resistant) P falciparum . In recent years, numerous of quinoline hybrids were developed, and their activities against a panel of drug‐resistant P falciparum strains were screened. Some of quinoline hybrids were found to possess promising in vitro and in vivo potency. This review emphasized quinoline hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug‐resistant P falciparum , covering articles published between 2010 and 2019.
Phase II Study of CPX-351 (Cytarabine: Daunorubicin) Liposome Injection in Patients (Pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) at High Risk for Induction Mortality
Authors: Gautam Borthakur, Hagop M. Kantarjian, Courtney D. DiNardo, Naval Daver, Elias J. Jabbour, Tapan Kadia, Guillermo Garcia-Manero, Farhad Ravandi, Naveen Pemmaraju, Marina Konopleva, Maro Ohanian, William G Wierda, Nitin Jain, Lian-Chun Xiao, Paromita Mukherjee, Mark Brandt, Jorge E. Cortes
Journal: Blood (2017)
High Activity of Cladribine (2-CdA) Combined with Low-Dose Cytarabine in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome after Azacitidine Failure
Authors: Kamil Wisniewski, Krzysztof Madry, Sebastian Grosicki, Piotr Małecki, Bartosz Pula, Marzena Watek, Ewa Lech-Maranda, Joanna Gora Tybor
Journal: Blood (2019)
Ruxolitinib (RUX) Induced Meaningful and Directional Changes in the Bone Marrow Microenvironment of Patients with Myelofibrosis Enrolled in the COMFORT-I Study
Authors: Hans Michael Kvasnicka, Juergen Thiele, Carlos E. Bueso-Ramos, Philomena Colucci, Dilan Paranagama, Srdan Verstovsek
Journal: Blood (2019)
Impact of Disease Status on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Refractory and Relapsed Acute Lymphoblastic Leukemia
Authors: Jing Cao, Xiaoming Zhu, Aining Sun, Huiying Qiu, Zhengming Jin, Miao Miao, Depei Wu, XiaoWen Tang
Journal: Blood (2016)
Smoking and Psychiatric Patients
Authors: D. Parr
Journal: BMJ (1963)

Residents' Quarters SIR,-In answer to the Minister's attempted foistering of the full costs of his incompetent hospital catering system upon the hapless heads of newly qualified compulsorily hospital-interned doctors, may I on behalf of many sufferers say this.The average standard of residential accommodation for young housemen is in any case doss-house.The conditions would be comical had they not in the past been "for-free" or for a nominal charge.Working his Dickensian 24-hour day, seven-day week in hospital, and forced to endure living in the hospital for the convenience of the hospital, the young doctor continues to be exploited.For generations he has been accustomed to an iron bedstead, no or non-fitting curtains, bedroom (not to mention its dual purpose of study/sitting-room) furniture which would be con- demned by a prison institute, and a standard of catering, reluctant, incompetent, and inadequate to such a degree that were an attempt ever made to force it down the throats of any but our sublimating innocents there would be instant rejection, let alone further brazen attempted extortion by the Minister.An unskilled worker may live in subsidized comfort on a well-planned housing estate, enjoying the benefits of good leadership and its accrued enlightened modern working conditions-good luck to him.Yet a young doctor, perhaps married and with a family, may have to go and live in the single garret residential unit com- pulsorily provided for him by the N.H.S. hospital at which he is to carry out a year-long sentence of separa- tion during his first job.Not to mention the financial embarrassment of maintaining two establishments at such a stage in his career.No wonder our hospital junior grades are now mainly and ever increasingly staffed by foreign doctors.-Iam, etc., Sheffield 8.
Performance measures for small-bowel endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
Authors: Cristiano Spada, Deirdre McNamara, Edward J. Despott, Samuel Adler, Brooks D. Cash, Ignacio Fernández-Urién, Hrvoje Ivekovic, Martin Keuchel, Mark McAlindon, Jean-Christophe Saurin, Simon Panter, Cristina Bellisario, Silvia Minozzi, Carlo Senore, Cathy Bennett, Michael Bretthauer, Mario Dinis-Ribeiro, Dirk Domagk, Cesare Hassan, Michal F. Kaminski, Colin J. Rees, Roland Valori, Raf Bisschops, Matthew D. Rutter
Journal: Endoscopy (2019)

Abstract The European Society of Gastrointestinal Endoscopy (ESGE) together with the United European Gastroenterology (UEG) recently developed a short list of performance measures for small-bowel endoscopy (i. e. small-bowel capsule endoscopy and device-assisted enteroscopy) with the final goal of providing endoscopy services across Europe with a tool for quality improvement. Six key performance measures for both small-bowel capsule endoscopy and for device-assisted enteroscopy were selected for inclusion, with the intention being that practice at both a service and endoscopist level should be evaluated against them. Other performance measures were considered to be less relevant, based on an assessment of their overall importance, scientific acceptability, and feasibility. Unlike lower and upper gastrointestinal endoscopy, where performance measures had already been identified, this is the first time that small-bowel endoscopy quality measures have been proposed.
Early Detection of Metastatic Prostate Cancer Relapse on 68Ga-PSMA-11 PET/CT in a Patient Still Exhibiting Biochemical Response
Authors: Nicolas Plouznikoff, Carlos Artigas, Spyridon Sideris, Thierry Gil, Patrick Flamen
Journal: Clinical Nuclear Medicine (2019)

Abstract Prostate cancer (PCa) treatment monitoring usually relies on prostate-specific antigen to detect disease progression or relapse. PET/CT with prostate-specific membrane antigen (PSMA) ligands has shown high accuracy in detecting metastatic PCa lesions and could help assess response to therapy. We describe herein the early relapse detection of a hormone-sensitive metastatic upfront PCa treated with docetaxel on 68 Ga-PSMA-11 PET/CT before biochemical progression. PSMA PET/CT should be considered to monitor PCa response to chemotherapy to detect early relapse, regardless of prostate-specific antigen levels, increasing the chances of finding low-volume oligoprogressive disease.
Predictive Factors of Response and Survival of Lenalidomide and Rituximab As Initial Treatment of Follicular Lymphoma
Authors: Paolo Strati, Ralph J. Johnson, Sheryl G Forbes, Loretta J. Nastoupil, Felipe Samaniego, Eric Davis, Michael R Green, Luis Fayad, F. B. Hagemeister, Jason R. Westin, Michael L. Wang, Sattva S Neelapu, Nathan H Fowler
Journal: Blood (2019)
Activity of Venetoclax-Based Therapy in Myelodysplastic Syndrome (MDS)
Authors: Jorge Cortes, Guillermo Garcia-Manero, Koji Sasaki, Kiran Naqvi, Yesid Alvarado, Tapan M. Kadia, Farhad Ravandi, Jorge E. Cortes, Naval G. Daver, Koichi Takahashi, Elias Jabbour, Gautam M. Borthakur, Naveen Pemmaraju, Marina Y Konopleva, Sherry A. Pierce, Carlos E. Bueso-Ramos, Keyur P. Patel, Hagop M. Kantarjian, Guillermo Montalban Bravo
Journal: Blood (2019)
A Thrombotic Biomarker-Based Risk Assessment Scoring Model for Disease Recurrence in Breast Cancer Patient Candidate to Systemic Chemotherapy
Authors: Anna Falanga, Cinzia Giaccherini, Marina Marchetti, Giovanna Masci, Cristina Verzeroli, Laura Russo, Luigi Celio, Roberta Sarmiento, Sara Gamba, Carmen J Tartari, Erika Diani, Alfonso Vignoli, Paolo Malighetti, Daniele Spinelli, Carlo Tondini, Sandro Barni, Francesco Giuliani, Fausto Petrelli, Andrea D'Alessio, Giampietro Gasparini, Filippo De Braud, Armando Santoro, Roberto Labianca
Journal: Blood (2019)
A Novel Algorithm for Treating Chronic Total Coronary Artery Occlusion
Authors: Hiroyuki Tanaka, Etsuo Tsuchikane, Toshiya Muramatsu, Koichi Kishi, Makoto Muto, Yuji Oikawa, Tomohiro Kawasaki, Yuji Hamazaki, Tsutomu Fujita, Osamu Katoh
Journal: Journal of the American College of Cardiology (2019)
Resuscitation of the newborn.
Authors: A Wilkinson
Journal: BMJ (1980)

The transition from intrauterine to extrauterine life takes only a few minutes but this is a crucial time during which serious problems may arise. The major complication is asphyxia and the management of this can directly affect later well being. Other factors associated with respiratory depression include aspiration syndromes, airway obstruction, sedation from analgesia given to the mother, trauma to the nervous system, and congenital malformations such as diaphragmatic hernia. A total of 6% of newborn infants require some form of assistance immediately after birth, and in those whose birth weight is less than 1500 g, this figure rises to 80%.’ Therefore a procedure for appropriate and immediately available resuscitation, which has been agreed by all the professionals involved, must be in place whenever and wherever babies are born.2 A successful outcome depends on anticipating or immediately recognising the need for resuscitation and then initiating the appropriate procedure promptly and skilfully. The need for neonatal resuscitation cannot always be predicted and so at least one person experienced in the methods should be available at every delivery. At high risk deliveries at least one member of the paediatric team should be present (Table 1). Additional personnel should be readily available, as resuscitation of a severely depressed infant requires at least two people: one to ventilate, and one to monitor, and if necessary, to perform cardiac massage. During prolonged resuscitation, the assistance of a third person to insert an intravenous cannula and give drugs may be required.
TNB383B.0001: A Multicenter, Phase 1, Open-Label, Dose-Escalation Andexpansion Study of TNB-383B, a Bispecific Antibodytargeting BCMA in Subjects with Relapsed or Refractorymultiple Myeloma
Authors: Ben Buelow, Anita D'Souza, Cesar Rodriguez, Ravi Vij, Rajneesh Nath, Melinda Snyder, Duy Pham, Ashwin Patel, Suhasini Iyer
Journal: Blood (2019)
Persistence of PNH Clones over Time: Insights from the Mid-Term Analysis of the French Nation-Wide Multicenter Prospective Observational Study
Authors: Magali Le Garff-Tavernier, Agathe Pruvot Debliquis, Thomas Boyer, Jean-Philippe Vial, Veronique Harrivel, Anne-Catherine Lhoumeau, Marie-Christine Jacob, Gerard Socie, Regis Peffault De Latour, Bernard Drenou, Orianne Wagner Ballon
Journal: Blood (2019)
Treatment of Leg Ulcers
Authors: R. S. Harvey
Journal: BMJ (1957)

No sclerosant is used, and the object is to eliminate the vein from the groin to the ankle, leaving no stretches open.This is undoubtedly time-consuming, but I consider the results we obtain justify it.The patient is encouraged to get about immediately, and in the majority of cases is fit to resume work after a fortnight, frequently less.Finally, I would join Mr. Dickson Wright in stressing the importance of the bandaging being done by the surgeons working in the clinic (as we do) or by someone whose experience is sufficient for them to carry out the treatment efficiently.-Iam, etc., Belfast.
Prothrombotic State, Platelet Activation and Netosis in Systemic Lupus Erythematosus
Authors: Elena Monzón Manzano, Ihosvany Fernandez-Bello, Raul Justo Sanz, Larissa Valor, Francisco Javier López-Longo, Angel Robles, Teresa Álvarez Roman, Miguel A Canales, Victor Jimenez-Yuste, Nora Butta
Journal: Blood (2019)
RARE-25. CLINICAL FEATURES OF PINEAL PARENCHYMAL TUMOR OF INTERMEDIATE DIFFERENTIATION (PPTID): A SINGLE INSTITUTION REVIEW
Authors: Katherine Kunigelis, Bette Kleinschmidt-DeMasters, D Ryan Ormond
Journal: Neuro-Oncology (2019)

Abstract Pineal parenchymal tumors of intermediate differentiation (PPTID) are rare. Even in the most recent WHO 2016, definitive histological criteria to distinguish grade II from III lesions remain to be defined. While no single institution has large numbers of cases, our experience has been that the clinical course is more varied and complicated than reported. The University of Colorado Health pathology database was queried for cases diagnosed as PPTID, 2006 – 2019, inclusive. Twelve adult patients were identified. Mean age at diagnosis was 40 years (range 26–78). There were 9 female and 3 male patients. Seven patients had well-documented clinical courses at our primary institution. At initial diagnosis, all were treated with surgery and 3/6 documented a gross total resection (GTR). Adjuvant radiation therapy to the resection bed in was administered in 5 of 7 (71%) of patients (4 IMRT, 1 SRS). Mean follow-up time was 71 months (range 13–195); 5/7 (71%) of patients developed a recurrence. Median progression free survival was 37 months (range 13- 73 months), with tendency to be longer for male gender (57.5 versus 17 months in females, p=0.17), and GTR (40 months versus 16 months in subtotal resection, p=0.49). Eighty percent of first recurrent disease had leptomeningeal dissemination. First recurrences were treated with radiation alone in 3 (60%) patients (1 SRS, 1 IMRT), craniospinal radiation with multi-agent chemotherapy in 1 (20%) patient, and surgery with radiation therapy in 1 (20%). At last follow-up, 2 patients (28.5%) had died, with median OS of 168.5 months. Although PPTIDs have a known potential for local recurrence and craniospinal dissemination (quoted as 22% and 10%, respectively in WHO 2016), our data show a more dismal experience with 71% recurrence and 80% dissemination at first recurrence. Lack of standardized therapies results in challenges in individual patient management.
RARE-51. RITUXIMAB, METHOTREXATE, BCNU, ETOPOSIDE, AND PREDNISONE (RMBVP) FOR THE TREATMENT OF RELAPSED/RECURRENT PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE SINGLE CENTER STUDY
Authors: Samantha Reiss, Prakirthi Yerram, Lisa Modelevsky, Christian Grommes
Journal: Neuro-Oncology (2019)

Abstract BACKGROUND Primary Central Nervous System Lymphoma (PCNSL) is an aggressive rare non-Hodgkin lymphoma. Prognosis is particularly poor for relapsed/recurrent (R/R) patients with no established treatment modality. Methotrexate/BCNU/Teniposide/Prednisone with or without rituximab has efficacy in newly diagnosed PCNSL. Here, we report efficacy and toxicity of RMBVP for the treatment of R/R PCNSL. METHODS This retrospective study at MSKCC included PCNSLs treated with MBVP for R/R disease between 5/2009 and 5/2019. Methotrexate (3.5 g/m2; day 1 and 15), etoposide (100 mg/m2; day 2), BCNU (100 mg/m2; day 3), prednisone (60 mg/m2/day; day 1–5) and rituximab (500 mg/m2; day 0 and 14) were given in 28-day cycles. Granulocyte colony-stimulating factor support was given for 5 days in between doses of chemotherapy. RESULTS Thirty patients received MBVP; 27 (90%) received RMBVP with a median of 2 cycles given (0.5–5). Median age was 66 years (23–81); median KPS was 70 (30–90); 14 (46.7%) were women. Median prior lines of therapy were 2 (1–5); all received prior methotrexate. Median time from last treatment was 1 month (0–88.3; 21 (70%) &lt; 12 months). Of twenty-nine evaluable patients for response, 23 (76.7%) had a response (9 complete response (CR) (30%), 5 CR-unconfirmed (16.7%), 8 partial response (26.7%), 1 stable disease (3%)). At a median follow up of 14.2 months, median progression free survival (PFS) was 15.6 months and median overall survival was not reached. Median PFS was poorer for patients with &lt; 12 months since last chemotherapy, 10.1 vs 60.6 months. Rates of serious (grade 3 or 4) neutropenia, anemia, thrombocytopenia and transaminitis were 20%, 20%, 16.7%, and 16.7%, respectively. One patient experienced grade 3 nephrotoxicity. No treatment related mortalities occurred. CONCLUSIONS RMBVP is a tolerable treatment option for R/R PCNSL, particularly in those with recurrent disease.
TMIC-56. ROLE OF HUMAN BRAIN TUMOR STEM CELLS-DERIVED EXTRACELLULAR VESICLES ON THE PHENOTYPIC TRANSDIFFERENTIATION OF HUMAN NEURAL PROGENITOR CELLS
Authors: Natanael Zarco, Emily Norton, Montserrat Lara-Velazquez, Anna Carrano, Alfredo Quinones-Hinojosa, Hugo Guerrero-Cazares
Journal: Neuro-Oncology (2019)

Abstract Glioblastoma (GBM) is the most aggressive of all the brain tumors with a median patient survival less than 15 months. Despite of surgical resection, radiotherapy, and chemotherapy, recurrence rate is almost 100%. A great percentage of GBM tumors (~60%) infiltrate and contact the ventricular-subventricular zone (V-SVZ). Interestingly, these tumors are the most aggressive, and invariably lead to higher distal recurrence rates, shorter time to tumor progression, and lower overall survival of the patient. The reason for this role of V-SVZ-proximity on the outcome of GBM patients is unknown. We suggest that a potential explanation is the interaction of GBM with the V-SVZ. This region is the largest neurogenic niche in the adult brain where neural stem cells (NSCs) give rise to newborn neuroblasts that migrate toward the olfactory bulb. In GBM there is a cell subpopulation called brain tumor stem cells (BTSCs) with NSCs-like characteristics, but with added potential for tumor initiation, recurrence and invasiveness. Tumor microenvironment plays an important role in migration and invasion process. In the present work, we used the total exosome isolation kit to purify Extracellular Vesicles (EVs) from human primary cultures of BTSCs. We determined that BTSCs-derived EVs contain specific information that is transfer to primary cultures of human Neural Progenitors Cells (NPCs) modulating their proliferation rate, cell viability, and migration. In addition, we identify that NPCs taken up BTSCs-derived EVs and significantly increase the expression levels of stemness-related genes such as Nestin, Nanog, and Sox2, suggesting that a phenotypic transdifferentiation is being carry out. These results support our hypothesis that GBM modulate the tumor microenvironment close to the V-SVZ by releasing EVs that target cellular components in this region and promote their phenotypic transformation, highlighting that NPCs biology changes in the context of tumor environment.
Enhancing Anti-Tumor Immunity and Responses to Immune Checkpoint Blockade By Suppressing Interleukin-10 in Chronic Lymphocytic Leukemia
Authors: Jacqueline R. Rivas, Sara S. Alhakeem, Joseph M. Eckenrode, Yinan Zhang, James P. Collard, Gerhard C. Hildebrandt, Roger A. Fleischman, Li Chen, Jon S. Thorson, Markos Leggas, Subbarao Bondada
Journal: Blood (2019)
Efficacy and Safety of Blinatumomab in Asian Adults with Relapsed/Refractory B-Precursor ALL
Authors: Yukio Kobayashi, Iekuni Oh, Toshihiro Miyamoto, Won-Sik Lee, Hiroatsu Iida, Hironobu Minami, Yoshinobu Maeda, Jun Ho Jang, Sung-Soo Yoon, Su-Peng Yeh, Qui Tran, Joan Morris, Janet L. Franklin, Ka-Wing Chong, Hitoshi Kiyoi
Journal: Blood (2019)
HDAC8 Maintain Cytoskeleton Integrity Via Homologous Recombination and Represent a Novel Therapeutic Target in Multiple Myeloma
Authors: Zuzana Chyra, Maria Gkotzamanidou, Masood A. Shammas, Vassilis L. Souliotis, Yan Xu, Mehmet K. Samur, Aaron B. Beeler, Roman Hajek, Mariateresa Fulciniti, Nikhil C. Munshi
Journal: Blood (2019)
High Expression of Decoy Receptor TRAIL-R3 on AML Blasts Is Associated to Shortened Overall Survival. TRAIL-R3 Induced Apoptosis Resistance Can Be Overcome by Specifically Targeting TRAIL-R2 in Vitro
Authors: Martine Chamuleau, Linda van Dreunen, S.M.G. Jirka, A. Zevenbergen, G. Ossenkoppele, Arjan A van de Loosdrecht
Journal: Blood (2008)
Interferon-γ and Tumor Necrosis Factor-α Induce An Immunoinhibitory Molecule, B7-H1, Via NfκB Activation in Blasts of Myelodysplastic Syndromes.
Authors: Asaka Kondo, Hideto Tamura, Taishi Yamashita, Chikako Sato, Zhao Wanhong, Takashi Tsuji, Eiji Shinya, Hidemi Takahashi, Koji Tamada, Lieping Chen, Kazuo Dan, Kiyoyuki Ogata
Journal: Blood (2009)
Phase 1 Study of Decitabine and Vorinostat Followed By Fludarabine, Cytarabine and G-CSF (FLAG) in Children, Adolescents and Young Adults with Relapsed/Refractory AML: Report from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium
Authors: Lauren Pommert, Deepa Bhojwani, Richard Sposto, Ellynore Florendo, Eric Schafer, Nathan Gossai, Van Thu Huynh, Sridhar Rao, Michael J. Burke
Journal: Blood (2019)
Tisagenlecleucel Manufacturing Feasibility in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia
Authors: Lamis K. Eldjerou, Christopher Acker, Damien Howick, Lee Clough, Miriam Fuchs, Florence Salmon, Jennifer Willert, Ranjan Tiwari, Mayo Pujols, Matthew Robson
Journal: Blood (2019)
MCL-1 Inhibition By the Selective MCL-1 Inhibitor AMG-176 Induces in Vitro Activity Against Burkitt Lymphoma Cell Lines and Synergistically Enhances the Cytotoxic Effect of Chemotherapy and BH3 Mimetics
Authors: Tara Daly, Thomas Ippolito, Juan J. Gu, Cory Mavis, Pallawi Torka, Francisco J. Hernandez-Ilizaliturri, Matthew J. Barth
Journal: Blood (2019)